Project Application

Entrepreneurial teams from ETH Zurich and the University of Zurich that have promising regenerative medicine and/or robotics technologies ready to be translated into groundbreaking therapies and/or products are encouraged to submit their project.

Application Process

Project Proposals are assessed by the Wyss Zurich Translational Center and the Wyss Zurich Foundation in a 4-step evaluation and selection process.

Applications may be submitted at any time of the year.

Application process

1. Screening

The Leadership team checks the Project Pre-Proposal submitted by the applicant(s) and assess whether the project meets the qualification criteria. Only projects that pass this formal eligibility test will be invited in writing to submit a Full-Proposal.

2. Scientific Assessment

The applicant(s) will pitch their Full-Proposal to the Scientific Board, which evaluates the scientific excellence and technical feasibility. The result of this pre-evaluation and a recommendation are submitted to the Evaluation Board and the Foundation Board.

3. Evaluation

The Evaluation Board evaluates Full-Proposals with respect to their clinical and commercial potential, medical and/or technological need, and the composition of the entrepreneurial team. The result of the evaluation and a recommendation are submitted to the Foundation Board.

4. Decision

The Foundation Board of the Wyss Zurich Foundation makes the funding decision based on a summary of key information and the recommendations of the Scientific and Evaluation Boards.

Qualification Criteria

Projects must have entrepreneurial potential and meet the following qualification criteria required for successful translation or technology transfer:

    • Scope: Regeneration of cells/tissue/organs to restore or establish functionality and health
  • The Wyss Zurich Translational Center (Wyss Zurich) does not support research activities; Wyss Zurich supports the advancements of therapies towards the clinic, the development of technologies towards the market as well as the clinic with the following activities:

    • Preclinical studies under GLP conditions
    • Production of clinical grade material under GMP certified conditions
    • Production of medical device technologies under ISO regulation
    • First-in-man studies and early phases of clinical trials

    • PoC of the regenerative technology must have been demonstrated in at least one relevant in-vivo model.
    • Projects must be supported by an innovative research background and scientific excellence.
    • Projects need to address an unmet need and face a valley of death concerning clinical translation / technology transfer.
    • The team must have a convincing business model and sound go-to-market considerations.
    • The team should act and be ready to grow as entrepreneurs with plans to continue the project beyond the Wyss Zurich Translational Center period.
    • Projects must demonstrate high market need and industry interest and the potential for scaling to an important business.
    • The product must be economically feasible with a preliminary business plan.
    • Products and technology need preliminary plans for scalable production.
    • Projects must have IP potential to provide opportunities for sustainable business and growth.
    • Relevant IP needs to be protected (e.g., patent application, software source code).
    • Candidates should be able to provide an overview on the competitive landscape to determine whether the development and commercialization of the technology/therapy is possible without infringing valid intellectual property rights of others (FTO).
    • Ownership of underlying IP should be with ETH Zurich and/or UZH.
    • If IP is partly/fully owned by a third party, a commercialization agreement is required to ensure that projects have unrestricted/exclusive access to the underlying IP.
    • A team leader(s) must be identified prior to the start of the Wyss Zurich project. This/these person/persons should demonstrate full commitment to pursue the project beyond the Wyss Zurich Translational Center period, to become an entrepreneur(s). The team leader must not be a faculty member.
    • Faculty members who are strongly involved with the project may be appointed as Faculty Mentors for the duration of the Wyss Zurich project.
    • Required key positions should be identified and ideally already filled.
    • Robotics Scope: Development of devices and technologies in the field of Robotics and intelligent systems
    • Medical Devices / Bionics Scope: Development of medical devices. Preferably, hybrid technologies from the fields of Regenerative Medicine and Robotics
  • The Wyss Zurich Translational Center (Wyss Zurich) does not support research activities; Wyss Zurich supports the advancements of therapies towards the clinic, the development of technologies towards the market as well as the clinic with the following activities:

    Robotics:

    • Elaboration of technical specifications (market-driven)
    • Design for production and optimization
    • Production of prototypes
    • Testing and validation up to early beta-testers
    • Product or components should be ready for industrial production at the end of the Wyss Zurich Translational Center period.

    Medical Technology / Bionics:

    • Elaboration of technical specifications
    • Design for production and optimization
    • Production of medical device/bionic technologies for validation according to applicable standards
    • Products should move to clinical validation and/or obtained Swiss or EU market authorization at the end of the Wyss Zurich Translational Center period.
    • A functioning prototype (software and/or hardware) of a technology must have been developed.
    • Projects must be supported by an innovative research background and scientific excellence.
    • Projects need to address an unmet need and face a valley of death concerning clinical translation / technology transfer.
    • The team must have a convincing business model and sound go-to-market considerations.
    • The team should act and be ready to grow as entrepreneurs with plans to continue the project beyond the Wyss Zurich Translational Center period.
    • Projects must demonstrate high market need and industry interest and the potential for scaling to an important business.
    • The product must be economically feasible with a preliminary business plan.
    • Products and technology need preliminary plans for scalable production.
    • Projects must have IP potential to provide opportunities for sustainable business and growth.
    • Relevant IP needs to be protected (e.g., patent application, software source code).
    • Candidates should be able to provide an overview on the competitive landscape to determine whether the development and commercialization of the technology/therapy is possible without infringing valid intellectual property rights of others (FTO).
    • Ownership of underlying IP should be with ETH Zurich and/or UZH.
    • If IP is partly/fully owned by a third party, a commercialization agreement is required to ensure that projects have unrestricted/exclusive access to the underlying IP.
    • A team leader(s) must be identified prior to the start of the Wyss Zurich project. This/these person/persons should demonstrate full commitment to pursue the project beyond the Wyss Zurich Translational Center period, to become an entrepreneur(s). The team leader must not be a faculty member.
    • Faculty members who are strongly involved with the project may be appointed as Faculty Mentors for the duration of the Wyss Zurich project.
    • Required key positions should be identified and ideally already filled.

Contact Form

Send us your contact details to initiate your project application process. It’s simple as that!

Please fill out this field

Please fill out this field

Please fill out this field

Please fill out this field

Please fill out this field

Please fill out this field

Please fill out this field